Results 321 to 330 of about 400,251 (340)

Low doses of ozone alleviate cardiomyocyte ferroptosis induced by hypoxia-reoxygenation injury via the AMPK-mTOR pathway. [PDF]

Eur J Med Res
Ding Y, Hong T.
europepmc   +1 more source

As a New Tumor Suppressor Gene, PID1 Activates the AMPK-mTOR Signal to Inhibit the Progression of Bladder Cancer. [PDF]

Res Rep Urol
Sun L, Liu C, Cao Y, Li J, Yuan L.
europepmc   +1 more source

Role of AMP-Activated Protein Kinase (AMPK) in Female Reproduction: A Review. [PDF]

Int J Mol Sci
Kamar Bashah NA, Hamid AA, Adam SH, Jaffar FHF, Abd Rahman IZ, Mokhtar MH.   +5 more
europepmc   +1 more source

mTOR Modulates NLRP3 Inflammasome Activation via Nuclear Translocation and STAT1 Inhibition. [PDF]

Eur J Immunol
González-Dominguez A, Zhang S, Boy-Ruiz D, Connors D, de la Varga-Martínez R, Mock BA, Cordero MD.   +6 more
europepmc   +1 more source

Circulating Levels of VEGF, mTOR and MAPK in Patients With Port-Wine Stains. [PDF]

J Cosmet Dermatol
Huang Y, Wu P, Yang J, Bi M, Cao L, Wang L.   +5 more
europepmc   +1 more source

Treinamento de força versus treinamento de endurance. Existe compatibilidade?

Revista Brasileira de Prescrição e Fisiologia do Exercício, 2012
Bernardo Neme Ide, Paloma Sampaio de Carvalho, Charles Ricardo Lopes, Mário Ferreira Sarraipa, Clodoaldo José Dechechi, Fernanda Lorenzi Lazarim, René Brenzikofer, Denise Vaz de Macedo   +7 more
doaj  

mTOR Pathway and mTOR Inhibitors in Cancer Therapy [PDF]

, 2010
1. N. Kubica and J. Blenis "mTORC1: A signaling integration node involved in cell growth" 2. Z. Feng and A.J. Levine "The Regulation of the IGF-1/mTOR Pathway by the p53 Tumor Suppressor Gene Functions" 3. H. Mead, M. Zeremski and M. Guba "mTOR Signaling in Angiogenesis" 4. J. Brugaroles "mTOR signaling and hypoxia" 5. D. Akhavan and P.S. Mischel "mTOR
Vitaly A. Polunovsky, Peter J. Houghton
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy

Hematology/Oncology Clinics of North America, 2012
Mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase. It is ubiquitously expressed in cells and is a therapeutic target for the cancer treatment arsenal. Despite the great responses obtained in tumors addicted to specific mutations or overactivation of key members of the mTOR pathway (HiF1α in RCC, cyclin D1 in MCL, or TSC in SEGA),
Alejandro Gomez-Pinillos, Anna C. Ferrari   +1 more
openaire   +3 more sources

mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy

Current Cancer Drug Targets, 2008
Research into mTOR, mammalian Target Of Rapamycin as an important drug target continues to be extremely interesting, both in terms of the increased molecular knowledge being acquired at the basis of various human diseases, and also for possible applications in drug cancer therapy.
Renzo Lazzarini, Elisa Giacomin, Stefano Marastoni, Barbara Ros, Sara Cecco, Paolo Baldo   +5 more
openaire   +3 more sources